PEOPLE - Changes at Abbott Laboratories:
This article was originally published in Clinica
Abbott Laboratories executive vice-president of the $4bn diagnostics division Edward Michael and executive vice-president of $1.1bn vascular medical devices division John Capek are among the group's four directors who will report directly to CEO Miles White following the sudden retirement of group No 2, COO Richard Gonzalez. Abbott is now committed to growing the diagnostics operation, after the recent collapse of GE's proposed $8.13bn takeover, but it has slipped to third in the world rankings, behind Roche and the Dade Behring-enhanced Siemens Medical Solutions Diagnostics.
You may also be interested in...
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.